Cargando…
Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model
PURPOSE: Pathologic corneal neovascularization is a major cause of blindness worldwide, and treatment options are currently limited. VEGF is one of the critical mediators of corneal neovascularization but current anti-VEGF therapies have produced limited results in the cornea. Thus, additional thera...
Autores principales: | Sun, Michel M., Chan, Ann M., Law, Samuel M., Duarte, Sergio, Diaz-Aguilar, Daniel, Wadehra, Madhuri, Gordon, Lynn K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336205/ https://www.ncbi.nlm.nih.gov/pubmed/30646013 http://dx.doi.org/10.1167/iovs.18-24345 |
Ejemplares similares
-
Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy
por: Sun, Michel, et al.
Publicado: (2020) -
Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants
por: Zhang, Liwei, et al.
Publicado: (2017) -
Overactivation of Norepinephrine–β2-Adrenergic Receptor Axis Promotes Corneal Neovascularization
por: Dong, Qiaoqiao, et al.
Publicado: (2023) -
Schwann Cells Are Key Regulators of Corneal Epithelial Renewal
por: Mirmoeini, Kaveh, et al.
Publicado: (2023) -
Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage
por: Wang, Bing, et al.
Publicado: (2018)